SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
19744725
Source:
http://linkedlifedata.com/resource/pubmed/id/19744725
Search
Subject
(
55
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0027627
,
umls-concept:C0030705
,
umls-concept:C0220633
,
umls-concept:C0279030
,
umls-concept:C0332167
,
umls-concept:C1522673
pubmed:issue
11
pubmed:dateCreated
2009-11-3
pubmed:abstractText
To examine whether interferon (IFN)-alfa-2a treatment after radiation or enucleation reduces death rates in patients with uveal melanoma.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19744725-20816255
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7802443
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha
,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins
,
http://linkedlifedata.com/resource/pubmed/chemical/interferon alfa-2a
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1549-4713
pubmed:author
pubmed-author:EganKathleen MKM
,
pubmed-author:GragoudasEvangelos SES
,
pubmed-author:HarmonDavidD
,
pubmed-author:HolbrookAmyA
,
pubmed-author:LaneAnne MarieAM
,
pubmed-author:MunzenriderJohn EJE
pubmed:issnType
Electronic
pubmed:volume
116
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2206-12
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:19744725-Antineoplastic Agents
,
pubmed-meshheading:19744725-Chemotherapy, Adjuvant
,
pubmed-meshheading:19744725-Eye Enucleation
,
pubmed-meshheading:19744725-Female
,
pubmed-meshheading:19744725-Humans
,
pubmed-meshheading:19744725-Interferon-alpha
,
pubmed-meshheading:19744725-Male
,
pubmed-meshheading:19744725-Melanoma
,
pubmed-meshheading:19744725-Middle Aged
,
pubmed-meshheading:19744725-Neoplasm Metastasis
,
pubmed-meshheading:19744725-Radiotherapy, Adjuvant
,
pubmed-meshheading:19744725-Recombinant Proteins
,
pubmed-meshheading:19744725-Risk Factors
,
pubmed-meshheading:19744725-Survival Rate
,
pubmed-meshheading:19744725-Treatment Outcome
,
pubmed-meshheading:19744725-Uveal Neoplasms
pubmed:year
2009
pubmed:articleTitle
Adjuvant interferon therapy for patients with uveal melanoma at high risk of metastasis.
pubmed:affiliation
Retina Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts 02114, USA. alane@meei.harvard.edu
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Research Support, Non-U.S. Gov't